Delcath Systems (NASDAQ: DCTH) insider transactions
In the twelve months to 10 November 2026, executives and directors of Delcath Systems reported 0 open-market sales and 4 open-market purchases of 32,619 shares ($287,457), by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 13 October 2026 | Rosalind Advisors, Inc. | Director | Conversion | +3,627 | — | 3,417,095 | Form 4 |
| 13 October 2026 | Rosalind Advisors, Inc. | Director | Other | −27,502 | — | 3,389,593 | Form 4 |
| 6 March 2026 | Pennell Sandra | Chief Financial Officer | Open-market purchase | +5,533 | $9.04 | 77,018 | Form 4 |
| 2 March 2026 | Michel Gerard J | Chief Executive Officer | Open-market purchase | +11,200 | $8.96 | 342,034 | Form 4 |
| 21 November 2025 | Sylvester John Richard | Director | Open-market purchase | +4,386 | $8.89 | 14,936 | Form 4 |
| 11 November 2025 | Michel Gerard J | Chief Executive Officer | Open-market purchase | +11,500 | $8.53 | 330,834 | Form 4 |
| 12 June 2025 | Vukovic Vojo | Chief Medical Officer | Option exercise | +42,000 | $4.78 | 168,882 | Form 4 |
| 5 May 2025 | Salamon Steven A J | Director | Option exercise | +400,000 | $10.00 | 3,413,468 | Form 4 |
| 5 May 2025 | Salamon Steven A J | Director | Option exercise | +400,000 | $10.00 | 3,413,468 | Form 4 |
| 5 May 2025 | Aharon Gil | Director | Option exercise | +400,000 | $10.00 | 3,413,468 | Form 4 |
| 24 December 2024 | Salamon Steven A J | Director | Conversion | +250,000 | $10.00 | 3,013,468 | Form 4 |
| 24 December 2024 | Rosalind Advisors, Inc. | Director | Conversion | +250,000 | $10.00 | 3,013,468 | Form 4 |
| 24 December 2024 | Aharon Gil | Director | Conversion | +250,000 | $10.00 | 3,013,468 | Form 4 |
| 22 October 2024 | Michel Gerard J | Chief Executive Officer | Option exercise | +16,666 | $6.00 | 319,334 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Delcath Systems page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.